What are the proper care and management guidelines for a Bivona tracheostomy tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bivona Tracheostomy Tube Care and Management

Bivona tracheostomy tubes require specific care protocols with particular attention to tube changes, cuff management, and monitoring for complications, following standardized institutional guidelines that prioritize airway safety and patient outcomes.

Immediate Post-Placement Care (Days 0-4)

The initial period after Bivona tracheostomy placement is critical and requires intensive monitoring 1:

  • Position verification: Ensure the tube tip is 4-6 cm from the carina with chest X-ray confirmation
  • Secure fixation: Use skin sutures, ties, or Velcro with movement limited to 1 finger width
  • Hemorrhage monitoring: Check for bleeding at the stoma site or during tracheal suctioning every 3 hours
  • Stoma care: Change dressings with isotonic saline 3 times daily to prevent secretion accumulation and moisture buildup
  • Cuff pressure: Maintain at <30 cmH₂O (typically 25-35 cmH₂O depending on institutional protocol)
  • Emergency equipment: Keep reintubation and tracheostomy equipment immediately available at bedside

Ongoing Daily Care

Standard maintenance protocols include 1:

  • Daily fixation changes (more frequently if oozing or bleeding present)
  • Daily stoma inspection and cleansing with isotonic saline
  • Tracheal suctioning to measured depth (to carina, then withdraw 1 cm and document distance)
  • Airway humidification with heated humidifier
  • Head elevation at 30° in midline position
  • Ensure ventilator tubing does not press on the stoma

Tube Change Timing and Indications

The first tube change should occur on postoperative day 5-7 2. This timing balances tract maturation against early complications. Earlier changes (before day 4-7) carry significant risks including tube displacement and respiratory arrest 1.

Subsequent tube changes are guided by clinical need rather than routine scheduling 1. Change the tube when:

  • Suspected local infection or bleeding
  • Need to downsize for speech facilitation
  • Structural tube deterioration (tubes show wall alterations after 30 days of use)
  • Obstruction or malfunction

The British Intensive Care Society recommends tubes without inner cannulas be changed every 7-14 days, while tubes with inner cannulas can remain for 30 days 1. However, clinical judgment supersedes fixed schedules.

Special Considerations for Bivona Tubes

Bivona tubes have unique characteristics requiring specific attention:

Foam-cuffed (FOME-CUF®) models are particularly useful for chronic aspiration management in pediatric patients, showing improved chest function without cuff trauma 3. However, these require specialized knowledge for emergency management.

Flexible Bivona tubes with adjustable length carry a specific risk: they assume a curve on insertion but exert straightening force (up to 0.21 Newton when bent 90°), which can cause tracheal ulceration, tissue distortion, or airway obstruction when the tip embeds into the tracheal wall 4. Monitor closely for these complications.

MRI compatibility: Bivona silicone tubes with reinforced wire are MRI-conditional, not MRI-safe 5. Before MRI, assess patient risk status—high-risk patients may proceed with restricted MRI conditions, while lower-risk patients should undergo tube change to an MRI-safe PVC tube (such as Shiley models).

Cuff Management

Deflate the cuff when the patient is breathing spontaneously 1. This practice reduces decannulation failure, shortens mechanical ventilation weaning time, and decreases tracheostomy-related complications.

For foam-cuffed Bivona tubes, never cut the pilot line—this creates removal difficulties requiring specialized management 3.

Culture and Antibiotic Stewardship

Obtain tracheal aspirate cultures only when there is concern for acute lower respiratory tract infection 6. Do not perform:

  • Routine surveillance cultures
  • Test-of-cure cultures after antibiotic treatment in clinically improving patients

This approach promotes antibiotic stewardship and avoids unnecessary testing that does not change management. Consider cultures for patients requiring hospital admission or markedly increased respiratory support, particularly those with impaired airway clearance, ventilator dependence, or immunocompromised states 6.

Monitoring for Airway Lesions

Common complications include suprastomal granulation tissue, tracheal stenosis, and mucosal ulceration 6. Symptomatic patients (with blood-tinged secretions, voice changes, dysphagia, or stoma obstruction) have significantly higher rates of airway lesions (70% vs 42% in asymptomatic patients) and may require bronchoscopic evaluation 6.

Critical Safety Points

  • Never perform the first tube change before day 4-7 due to immature tract and displacement risk
  • Always have emergency airway equipment immediately available, especially during the first 7-10 days
  • Monitor for the specific Bivona complication of tracheal wall embedding due to tube straightening forces
  • Ensure all personnel are trained in Bivona-specific emergency management, particularly for foam-cuffed models
  • Verify MRI compatibility before imaging and follow institutional protocols for MRI-conditional tubes

Related Questions

When is a Bivona tracheostomy tube preferred over a standard cuffed PVC tracheostomy tube?
What are cuffed and fenestrated tracheostomy tubes, and how do they differ?
What are the differences between Jackson and Shiley tracheostomy tubes?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the optimal structure for an emergency department (ED) patient handover, including patient identification, vital signs, oxygen requirement, mental status, allergies, medication list (especially recent changes such as anticoagulants, insulin, or cardiac drugs), pertinent past medical history, primary assessment findings, urgent investigation results, interventions performed, response to treatment, pending tests, next steps, planned disposition, and any safety concerns?
What is the appropriate treatment for a Grade 1 pressure ulcer?
Should a patient with acute leukemia who has a low-grade fever and worsening cough present to the emergency department?
In a zone 1 thoracic endovascular aortic repair using a through‑and‑through wire placed from the right axillary artery to the right femoral artery, should the wire tip be positioned in the ascending aorta during graft deployment, and how should the wire be managed?
What are the ASCO guidelines for managing immune checkpoint inhibitor (ICI)–induced Evans syndrome?
When is a Bivona tracheostomy tube preferred over a standard cuffed PVC tracheostomy tube?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.